Robbie Marcus

Q: What is Robbie Marcus's success rate?

Robbie Marcus currently has a success rate of 97.1168915472713.

Q: What is the average return of Robbie Marcus's calls?

Their stock ratings have generated an average return of 34.04255504656105.

JP Morgan | Healthcare

Robbie Marcus is an analyst from JP Morgan specializing in the Healthcare sector. Ranked #426 out of 4779 analysts, they have issued 36 stock ratings with a success rate of 97.12% and an average return of 34.04%.

Robbie Marcus has a well-established track record, with 36 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 97.12% and an average return of 34.04%, underscoring their expertise and ability to identify winning opportunities for investors.

#426

Out of 4779

Total Ratings

+97.12%

Success Rate

+34.04%

Average Return

Recent Ratings Analysis

COO

Hold

Sep 10, 2026

Target

$71.00

Current

$55.29

Performance

2.07%

Robbie Marcus rated COO as Neutral on Sep 10, 2026, setting a price target of 71. The Hold stance appears justified, as shares hovered around 55.29 with a 2.07% move.

PODD

Hold

Aug 06, 2026

Target

$152.00

Current

$140.60

Performance

0.93%

On Aug 06, 2026, PODD was given a Neutral rating by Robbie Marcus, with a target price of 152. Market indecision, reflected in sideways trading near 140.6, supported the cautious call.

INSP

Hold

Aug 04, 2026

Target

$60.00

Current

$76.78

Performance

19.71%

INSP received a Neutral rating from Robbie Marcus on Aug 04, 2026, aiming for 60. Investors saw gains of 19.71% that the cautious stance didn’t fully capture.

SYK

Buy

Jul 31, 2026

Target

$350.00

Current

$275.12

Performance

-15.53%

On Jul 31, 2026, Robbie Marcus published a Overweight outlook on SYK, with a target of 350. Market action contradicted the Buy thesis, as shares slipped to 275.12.

MMSI

Buy

Jul 31, 2026

Target

$95.00

Current

$85.37

Performance

0.42%

Robbie Marcus on Jul 31, 2026 assigned MMSI a Overweight rating, with a price target of 95. The recommendation remains pending validation as shares consolidate around 85.37.

DXCM

Hold

Jul 31, 2026

Target

$82.00

Current

$89.35

Performance

7.07%

On Jul 31, 2026, Robbie Marcus reaffirmed DXCM with a Neutral rating, targeting 82. Market strength beyond 89.35 went further than the conservative outlook suggested.

EW

Buy

Jul 24, 2026

Target

$105.00

Current

$88.26

Performance

6.81%

EW was rated Overweight by Robbie Marcus on Jul 24, 2026, with a price objective of 105. A bullish response from the market helped close the gap of 16.74 to the target.

ABT

Buy

Jul 17, 2026

Target

$120.00

Current

$102.55

Performance

1.86%

On Jul 17, 2026, Robbie Marcus initiated coverage on ABT with a Overweight rating and target of 120. Neutral price movement of 1.86% leaves room for interpretation.

ISRG

Buy

Jul 17, 2026

Target

$450.00

Current

$393.33

Performance

13.87%

Robbie Marcus issued a Overweight recommendation for ISRG on Jul 17, 2026, price target set at 450. Investors following the Buy call captured upside momentum, with shares now at 393.33.

MOBI

Buy

Jun 02, 2026

Target

$15.00

Current

$10.54

Performance

—

On Jun 02, 2026, MOBI was evaluated by Robbie Marcus, who gave a Overweight rating and target of 15. So far, the Buy call awaits clearer momentum, with shares flat at 10.54.

CNMD

Hold

Apr 30, 2026

Target

$40.00

Current

$45.42

Performance

23.90%

Robbie Marcus rated CNMD as Neutral on Apr 30, 2026, setting a price target of 40. Despite the Hold call, shares climbed 23.90% to 45.42, revealing unexpected momentum.

GEHC

Hold

Apr 30, 2026

Target

$65.00

Current

$64.13

Performance

5.41%

On Apr 30, 2026, GEHC was given a Neutral rating by Robbie Marcus, with a target price of 65. The stock rallied from 64.13 to 64.13 after the Hold rating, surprising to the upside.

ZBH

Hold

Apr 29, 2026

Target

$95.00

Current

$95.36

Performance

19.10%

ZBH received a Neutral rating from Robbie Marcus on Apr 29, 2026, aiming for 95. Investors saw gains of 19.10% that the cautious stance didn’t fully capture.

HTFL

Buy

Mar 19, 2026

Target

$35.00

Current

$50.75

Performance

96.02%

On Mar 19, 2026, Robbie Marcus published a Overweight outlook on HTFL, with a target of 35. Shares gained 96.02%, underscoring the accuracy of the bullish outlook toward 35.

MDT

Hold

Feb 18, 2026

Target

$105.00

Current

$92.13

Performance

-6.46%

Robbie Marcus on Feb 18, 2026 assigned MDT a Neutral rating, with a price target of 105. The call successfully avoided chasing as shares lost 6.46%.

BSX

Buy

Feb 05, 2026

Target

$100.00

Current

$43.34

Performance

-44.18%

On Feb 05, 2026, Robbie Marcus reaffirmed BSX with a Overweight rating, targeting 100. Shares slid 44.18% despite the recommendation, highlighting downside risks.

RXST

Sell

Nov 06, 2025

Target

$9.00

Current

$5.20

Performance

-39.61%

RXST was rated Underweight by Robbie Marcus on Nov 06, 2025, with a price objective of 9. The Sell stance proved too pessimistic given the -39.61% climb.

CBLL

Buy

Nov 05, 2025

Target

$17.00

Current

$24.37

Performance

106.88%

On Nov 05, 2025, Robbie Marcus initiated coverage on CBLL with a Overweight rating and target of 17. The stock’s climb of 106.88% since the call highlights the foresight in the rating.

IART

Sell

Oct 31, 2025

Target

$13.00

Current

$15.22

Performance

26.73%

Robbie Marcus issued a Underweight recommendation for IART on Oct 31, 2025, price target set at 13. The bearish outlook played out, as shares fell from 15.22 to 15.22.

BLCO

Hold

Oct 30, 2025

Target

$16.00

Current

$16.85

Performance

11.29%

On Oct 30, 2025, BLCO was evaluated by Robbie Marcus, who gave a Neutral rating and target of 16. Investors who stayed in despite the Hold saw upside of 11.29%.

BAX

Hold

Feb 21, 2025

Target

$36.00

Current

$22.80

Performance

-32.58%

Robbie Marcus rated BAX as Neutral on Feb 21, 2025, setting a price target of 36. The cautious Hold call aligned with subsequent weakness, as shares slipped 32.58%.

BVS

Hold

Dec 17, 2024

Target

$13.00

Current

$12.91

Performance

15.78%

On Dec 17, 2024, BVS was given a Neutral rating by Robbie Marcus, with a target price of 13. The stock rallied from 12.91 to 12.91 after the Hold rating, surprising to the upside.

NPCE

Buy

Dec 17, 2024

Target

$14.00

Current

$14.28

Performance

23.96%

NPCE received a Overweight rating from Robbie Marcus on Dec 17, 2024, aiming for 14. Momentum has favored the Buy call, with shares climbing from 14.28 to 14.28, rewarding those who trusted the recommendation.

ATRC

Buy

Jul 31, 2024

Target

$30.00

Current

$58.10

Performance

169.36%

On Jul 31, 2024, Robbie Marcus published a Overweight outlook on ATRC, with a target of 30. Shares gained 169.36%, underscoring the accuracy of the bullish outlook toward 30.

TMCI

Hold

May 08, 2024

Target

$8.00

Current

$4.49

Performance

7.67%

Robbie Marcus on May 08, 2024 assigned TMCI a Neutral rating, with a price target of 8. Shares outperformed expectations, climbing 7.67% despite the neutral view.

SILK

Hold

May 01, 2024

Target

$21.00

Current

$27.49

Performance

36.36%

On May 01, 2024, Robbie Marcus reaffirmed SILK with a Neutral rating, targeting 21. Market strength beyond 27.49 went further than the conservative outlook suggested.

CVRX

Hold

May 01, 2024

Target

$13.00

Current

$3.04

Performance

-69.96%

CVRX was rated Neutral by Robbie Marcus on May 01, 2024, with a price objective of 13. Investors who stayed cautious avoided some of the 69.96% decline.

Frequency Asked Questions

Who is Robbie Marcus?

Robbie Marcus is an analyst from JP Morgan specializing in the Healthcare sector.

What is Robbie Marcus's success rate?

Robbie Marcus currently has a success rate of +97.12%.

How many ratings has Robbie Marcus issued?

Robbie Marcus has issued 36 stock ratings so far.

What is the average return of Robbie Marcus's calls?

Their stock ratings have generated an average return of +34.04%.

What is Robbie Marcus's ranking?

Robbie Marcus is ranked #426 out of 4779 analysts.

What types of ratings does Robbie Marcus give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Robbie Marcus?

You can follow Robbie Marcus by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Robbie Marcus?

Their latest rating was a Hold on COO issued on 2026-09-10.